glp-1 drugs manufacturers suppliers distributors 2023-2025 Obesity Market 2025’s Breakthrough GLP-1 Obesity Treatments:
Description
The rise of GLP-1 receptor agonists has ignited what experts are calling the GLP-1 Revolution
As part of our routine safety review process for Mounjaro (tirzepatide) and Zepbound (tirzepatide) we have ongoing discussions with regulators regarding potential safety topics, and we will continue to review data, including any data regarding ophthalmic issues
Among these, 6% are currently using such a drug
Reaven et al
This paradigm shift represents both a challenge and an unprecedented opportunity for CPG companies to fit into consumers changing lives
